We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Balloon-Occluded Esophageal Variceal Obliteration Procedure: A Novel Technique Report from Three Centers.
- Authors
Zhang, Qianqian; Mei, Xuecan; Zhang, Fumin; Jin, Jing; Zeng, Zhuang; Wang, Jin-guang; Wu, Chengbao; Kong, Derun
- Abstract
Introduction: Esophageal variceal bleeding (EVB) is a potentially fatal complication of cirrhosis. The purpose of the present study was to evaluate the safety and efficacy of a novel technique of balloon-occluded esophageal varices (EVs) obliteration (BEVO) for EVs classified as F2 (medium size, F2-EVs) and F3 (large size, F3-EVs). Materials and Methods: Between December 2020 and December 2021, a total of 73 consecutive patients with EVs were treated using BEVO. An injection of sclerosant was administered via direct puncture of the varices during balloon occlusion. Immediate postprocedural Doppler endoscopic ultrasonography (EUS) was conducted to evaluate the blood flow in the EVs. Several factors, including the technical success, controlling of acute bleeding, intraoperative bleeding at the injection site, variceal eradication, variceal recurrence, and BEVO-related complications, were assessed. Results: BEVO was successfully performed in all patients. Immediate hemostasis was achieved in 100% (25/25) of patients with active EVB. The incidence of injection site intraoperative bleeding presenting as oozing and spurting bleeding was 76.71% (56/73) and 8.22% (6/73), respectively. Based on Doppler EUS and endoscopic examination, EVs were completely eradicated in 71 out of 73 patients (97.26%) after three sessions. A total of 3 (4.11%) patients were diagnosed with EV recurrence during follow-up after complete EV eradication. Retrosternal chest discomfort (13.70%; 10/73) and abdominal bloating (2.74%; 2/73) were spontaneously relieved after a few days. No serious BEVO-related complications were observed. Discussion: BEVO is a convenient and effective treatment for obliterating F2 and F3 EVs. Clinical Trial Registration No. ChiCTR2000039974.
- Subjects
ENDOSCOPIC ultrasonography; ESOPHAGEAL varices; DOPPLER ultrasonography; ABDOMINAL bloating; CHEST pain
- Publication
Journal of Laparoendoscopic & Advanced Surgical Techniques, 2023, Vol 33, Issue 1, p87
- ISSN
1092-6429
- Publication type
Article
- DOI
10.1089/lap.2022.0416